EDIT vs. GLD
EDIT (Editas Medicine, Inc.) is a stock, while GLD (SPDR Gold Shares) is Gold fund tracking the LBMA Gold Price PM. Over the past 10 years, EDIT returned -22.22%/yr vs 12.15%/yr for GLD. At a 0.04 correlation, their price movements are largely independent.
Performance
EDIT vs. GLD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, EDIT achieves a 21.95% return, which is significantly higher than GLD's -2.47% return. Over the past 10 years, EDIT has underperformed GLD with an annualized return of -22.22%, while GLD has yielded a comparatively higher 12.15% annualized return.
EDIT
- 1D
- 2.46%
- 1M
- -4.58%
- YTD
- 21.95%
- 6M
- -1.19%
- 1Y
- 26.90%
- 3Y*
- -39.82%
- 5Y*
- -41.79%
- 10Y*
- -22.22%
GLD
- 1D
- 0.06%
- 1M
- -7.37%
- YTD
- -2.47%
- 6M
- -2.25%
- 1Y
- 22.21%
- 3Y*
- 28.89%
- 5Y*
- 17.08%
- 10Y*
- 12.15%
EDIT vs. GLD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
EDIT Editas Medicine, Inc. | 21.95% | 61.42% | -87.46% | 14.21% | -66.59% | -62.13% | 136.78% | 30.15% | -25.97% | 89.34% |
GLD SPDR Gold Shares | -2.47% | 63.68% | 26.66% | 12.69% | -0.77% | -4.15% | 24.81% | 17.86% | -1.94% | 12.81% |
Correlation
The correlation between EDIT and GLD is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.23 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.14 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.09 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.05 |
Correlation (All Time) Calculated using the full available price history since Feb 3, 2016 | 0.04 |
The correlation between EDIT and GLD shifts across timeframes, from 0.04 (all time) to 0.23 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EDIT vs. GLD — Risk / Return Rank
EDIT
GLD
EDIT vs. GLD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Editas Medicine, Inc. (EDIT) and SPDR Gold Shares (GLD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| EDIT | GLD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.72 | ||
| Sortino ratioReturn per unit of downside risk | -0.25 | ||
| Omega ratioGain probability vs. loss probability | 1.11 | 1.18 | -0.07 |
| Calmar ratioReturn relative to maximum drawdown | 0.25 | 0.98 | -0.73 |
| Martin ratioReturn relative to average drawdown | 0.43 | 2.81 | -2.38 |
Loading charts...
Drawdowns
EDIT vs. GLD - Drawdown Comparison
The maximum EDIT drawdown since its inception was -98.92%, which is greater than GLD's maximum drawdown of -45.56%. Use the drawdown chart below to compare losses from any high point for EDIT and GLD.
Loading charts...
Drawdown Indicators
| EDIT | GLD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.92% | -45.56% | -53.36% |
Max Drawdown (1Y)Largest decline over 1 year | -59.88% | -24.46% | -35.42% |
Max Drawdown (3Y)Largest decline over 3 years | -91.18% | -24.46% | -66.72% |
Max Drawdown (5Y)Largest decline over 5 years | -98.66% | -24.46% | -74.20% |
Max Drawdown (10Y)Largest decline over 10 years | -98.92% | -24.46% | -74.46% |
Current DrawdownCurrent decline from peak | -97.24% | -22.05% | -75.19% |
Average DrawdownAverage peak-to-trough decline | -62.63% | -16.16% | -46.47% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 34.03% | 8.49% | +25.54% |
Volatility
EDIT vs. GLD - Volatility Comparison
Editas Medicine, Inc. (EDIT) has a higher volatility of 32.34% compared to SPDR Gold Shares (GLD) at 7.79%. This indicates that EDIT's price experiences larger fluctuations and is considered to be riskier than GLD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| EDIT | GLD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 32.34% | 7.79% | +24.55% |
Volatility (6M)Calculated over the trailing 6-month period | 61.63% | 24.10% | +37.53% |
Volatility (1Y)Calculated over the trailing 1-year period | 94.75% | 27.37% | +67.38% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 94.12% | 18.22% | +75.90% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 83.80% | 16.08% | +67.72% |
Dividends
EDIT vs. GLD - Dividend Comparison
Neither EDIT nor GLD has paid dividends to shareholders.
Frequently Asked Questions
EDIT and GLD have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
EDIT has higher volatility (32.34%) compared to GLD (7.79%). In terms of maximum drawdown, EDIT dropped -98.92% vs GLD's -45.56%.
GLD currently has the higher Sharpe Ratio (0.87 vs 0.16), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for EDIT and GLD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer